An evaluation of risk factors affecting amputation in patients with diabetic foot Infection

Abstract

Introduction: Diabetic foot infections are one of the most common complications of diabetes and generally result in lower extremity amputations. Aim: The purpose of this study is to investigate risk factors affecting amputation in patients diagnosed with diabetic foot ulcer. Materials and Methods: This prospective cohort study involved 137 patients diagnosed with diabetic foot infection in a university hospital diabetic foot clinic. Results: The mean age of the participants was 60.5±10.1 years, and 70.8% (n=97) were men. The majority of patients (62.0%) were educated to elementary or middle school level, while 26.3% were illiterate. Mean duration of diabetes was 13.3±6.2 years. Hypertension was present in 48.2% of patients, hypercholesterolemia in 31.4%, cardiovascular disease (CVD) in 38%, peripheral artery disease (PAD) in 21.2%, peripheral venous insufficiency in 10.2%, and polyneuropathy in 70.1%, and 9.5% were receiving hemodialysis. According to the Infectious Diseases Society of America classification, moderate foot ulcers were present in 60.6% of patients, mild ulcers in 34.3%, and severe ulcers in 5.1%. Forty-six percent of patients were diagnosed with osteomyelitis during follow-up. Amputation was present in 28.5% (n=39) of the patients followed-up due to foot ulcers. PAD increased the risk of amputation 2.7-fold (95% CI: 1.02-7.14), osteomyelitis 2.6-fold (95% CI: 1.10-6.16), and repeated hospitalizations 5.9-fold (95% CI: 2.25-15.33). Growth was observed in 72.6% of patients without amputation, 76.5% were polymicrobial, and 65.9% of antibiogram results were multidrug resistant. No significant difference was observed among the patients in terms of multidrug resistance (p=0.468). Conclusion: PAD, osteomyelitis, and history of repeated hospitalizations are separate risk factors for amputation in patients with diabetic foot ulcers.

Keywords

• Diabetic foot
• amputation
• risk factors
• infection
• multidrug resistance

References

1. International Diabetes Federation, IDF Diabetes Atlas, International Diabetes Federation, Brussels, Belgium, 8th edition, 2017.
2. Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis (dagger). Ann Med 2017; 49: 106-16.
3. Apelqvist J, Larsson J. What is the most effective way to reduce incidence of amputation in the diabetic foot? Diabetes Metab Res Rev 2000; 16: S75-83.
4. Chronic Complications of Diabetes, Diabetes and Foot. National Diabetes Consensus Group. TURKDIAB Diabetes Diagnosis and Treatment Guideline 2019; 121-30.
5. Brownrigg JRW, Griffin M, Hughes CO, et al. Influence of foot ulceration on cause-specific mortality in patients with diabetes mellitus. J Vasc Surg 2014; 60: 982–6.
6. Turhan V, Mutluoglu M, Acar A, et al. Increasing incidence of Gram-negative organisms in bacterial agents isolated from diabetic foot ulcers. J Infect Dev Ctries 2013; 7: 707-12.
7. Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med 2017; 376: 2367.
8. Lipsky BA, Berendt AR, Cornia PB, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2012; 54: 132-73.

9. Neves J, Matias R, Formiga A, et al. O pé diabético com infecção aguda: tratamento no Serviço de Urgência em Portugal. Rev Port Cir 2013; 27: 19-36.
10. Sánchez-Sánchez M, Cruz-Pulido WL, Bladinieres-Cámara E, AlcaláDurán R, Rivera-Sánchez G, Bocanegra-García V. bacterial prevalence and antibiotic resistance in clinical isolates of diabetic foot ulcers in the Northeast of Tamaulipas, Mexico. Int J Low Extrem Wounds 2017; 16: 129-34.
11. Spicler A, Hurwitz BL, Armstrong DG, Lipsky BA. Microbiology of diabetic foot infections: from Luis Pasteur to ‘crime scene investigation’. BMC Med 2015; 13: 1-13.
12. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drugresistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18: 268–81.
13. Barwell ND, Devers MC, Kennon B, et al. Scottish diabetes foot action group. Diabetic foot infection: antibiotic therapy and good practice recommendations. Int J Clin Pract 2017; 71: 10.1111/ijcp.13006.
14. Apelqvist J, Larsson J. What is the most effective way to reduce incidence of amputation in the diabetic foot? Diabetes Metab Res Rev 2000; 16: 75-83.
15. Baba M, Davis WA, Norman PE, Davis TME. Temporal changes in the prevalence and associates of diabetes-related lower extremity amputations in patients with type 2 diabetes: the Fremantle Diabetes Study. Cardiovasc Diabetol 2015; 14: 1-10.
16. De Jesus-Silva SG, De Oliveira JP, Colepicolo Brianezi MH, De Moraes Silva MA, Krupa AE, Cardoso RS. Analysis of risk factors related to minor and major lower limb amputations at a tertiary hospital. J Vasc Bras 2017; 16: 16-22.
17. Namgoong S, Jung S, Han SK, Jeong SH, Dhong ES, Kim WK. Risk factors for major amputation in hospitalised diabetic foot patients. Int Wound J 2016; 13: 13-9.
18. Moon KC, Kim SB, Han SK, Jeong SH, Dhong ES. Risk factors for major amputation in hospitalized diabetic patients with forefoot ulcers. Diabetes Res Clin Pract 2019; 158: 107905.
19. Al-Mahroos F, Al-Roomi K. Diabetic neuropathy, foot ulceration, peripheral vascular disease and potential risk factors among patients with diabetes in Bahrain: a nationwide primary care diabetes clinic-based study. Ann Saudi Med 2007; 27: 25-31.
20. Bruun C, Siersma V, Guassora AD, Holstein P, de Fine Olivarius N. Amputations and foot ulcers in patients newly diagnosed with type 2 diabetes mellitus and observed for 19 years. The role of age, gender and co-morbidity. Diabet Med 2013; 30: 964-72.
21. Larsson LG, Baum J, Mudholkar GS. Hypermobility: features and differential incidence between the sexes. Arthritis Rheum. 1987; 30: 1426-30.
22. Cheng YJ, Gregg EW, Kahn HS, Williams DE, De Rekeneire N, Narayan KM. Peripheral insensate neuropathy-a tall problem for US adults? Am J Epidemiol 2006; 164: 873-80.
23. Hjelm K, Nyberg P, Apelqvist J. Gender influences beliefs about health and illness in diabetic subjects with severe foot lesions. J Adv Nurs 2002; 40: 673-84.
24. Orneholm H, Apelqvist J, Larsson J, Eneroth M. High probability of healing without amputation of plantar forefoot ulcers in patients with diabetes. Wound Repair Regen 2015; 23: 922-31.
25. Al-Rubeaan K, Youssef AM, Ibrahim HM, et al. All-cause mortality and its risk factors among type 1 and type 2 diabetes mellitus in a country facing diabetes epidemic. Diabetes Res Clin Pract 2016; 118: 130-9.
26. Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care 1999; 22: 1036-42.
27. Shatnawi NJ, Al-Zoubi NA, Hawamdeh HM, Khader YS, Garaibeh K, Heis HA. Predictors of major lower limb amputation in type 2 diabetic patients referred for hospital care with diabetic foot syndrome. Diabetes Metab Syndr Obes 2018; 11: 313-9.
28. Pscherer S, Dippel FW, Lauterbach S, Kostev K. Amputation rate and risk factors in type 2 patients with diabetic foot syndrome under real-life conditions in Germany. Prim Care Diabetes 2012; 6: 241-6.
29. Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004; 141: 421–31.
30. Winkley K, Stahl D, Chalder T, Edmonds ME, Ismail K. Risk factors associated with adverse outcomes in a population-based prospective cohort study of people with their first diabetic foot ulcer. J Diabetes Complications 2007; 21: 341–9.
31. Cardoso HC, Zara ALSA, Rosa SSRF, et al. Risk factors and diagnosis of diabetic foot ulceration in users of the Brazilian public health system. J Diabetes Res 2019; 2019: 5319892.
32. Namgoong S, Jung S, Han SK, Jeong SH, Dhong ES, Kim WK. Risk factors for major amputation in hospitalised diabetic foot patients. Int Wound J. 2016 Mar; 13 Suppl 1: 13-9.
33. Al-Rubeaan K, al Derwish M, Ouizi S, et al. Diabetic foot complications and their risk factors from a large retrospective cohort study. PLoS One 2015; 10: e0124446.
34. Khawaja N, Abu-Shennar J, Saleh M, Dahbour SS, Khader YS, Ajlouni KM. The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; the case of Jordan. Diabetol Metab Syndr. 2018; 10: 8.
35. Nelson RG, Gohdes DM, Everhart JE, et al. Lower-extremity amputations in NIDDM. 12-yr follow-up study in Pima Indians. Diabetes Care 1988; 11: 8–16.
36. Chaturvedi N, Stevens LK, Fuller JH, Lee ET, Lu M. Risk factors, ethnic differences and mortality associated with lower-extremity gangrene and amputation in diabetes. The WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001; 44: S65-S71.
37. Faglia E. Characteristics of peripheral arterial disease and its relevance to the diabetic population. Int J Low Extrem Wounds 2011; 10: 152–66.
38. Oliveira AFD, Oliveira Filho HD. Microbiological species and antimicrobial resistance profile in patients with diabetic foot infections. J Vasc Bras 2014; 13: 289-93.
39. Oliva A, Giacobbe DR, Di Luca M, Miller NS. New ınsights into ınfections due to multidrug resistant gram negative bacteria: the ınterplay between lab and clinic. Biomed Res Int 2018; 2018: 8905874.